Asia’s fourth-largest economy added 1.13 million positions in the first month of 2022 from a year earlier, led by medical and welfare industries

The biotech firm's shares were trading up 7% by mid-session, their biggest intraday gain since March 2020

Kyungsun Chung, co-founder and a managing partner of Sylvan, said investments were made from its Sylvan Asia Growth Fund I

The ARCoV vaccine, developed by the Academy of Military Medical Sciences (AMMS), Suzhou Abogen Biosciences and Walvax Biotechnology, is being tested in an international Phase III trial

The directive increases pressure on authorities scrambling to keep pace with a deluge of new infections in the financial hub

NIG was due to begin operations on Wednesday but the controversial plans have been postponed due to Covid-19, an official told Nikkei Asia

The company will "explore partnerships in providing accurate, affordable and accessible cancer early detection to the Hong Kong and Greater Bay Area communities"

The city's chief executive said she could not "preclude" the possibility of postponing the city's chief executive election, due in March

The world's third-largest economy expanded an annualised 5.4% in October-December after contracting a revised 2.7% in the previous quarter

Continued opening of vaccinated travel lanes with over 20 countries despite global surge in Covid-19 cases reflects commitment, Deputy PM Heng Swee Keat said

The move comes as over 1,600 trucks are stuck at border gates in the north awaiting clearance from the Chinese side, the report said

Vietnam will remove its Covid-19 curbs on international flights with all markets starting Tuesday February 15, with no limit on the number of flights, state-run Tuoi Tre paper reported on Sunday.